| 3002.20.00.00 | Pharmaceutical products: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine |
Trending Over Time: All Countries (USD)
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
$64,589,246.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-01 $50,620,924.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-02 $83,964,312.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-03 $72,254,395.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-04 $83,800,332.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-05 $93,204,383.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-06 $151,386,339.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-07 $175,209,787.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-08 $254,971,959.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-09 $219,860,859.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-10 $359,122,389.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-11 $418,135,635.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-12 $226,428,585.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-01 $173,401,719.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-02 $178,031,714.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-03 $61,209,781.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-04 $82,470,143.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-05 $157,839,105.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-06 $262,446,343.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-07 $382,206,289.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-08 $232,362,721.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-09 $130,494,466.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-10 $43,725,856.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-11 $75,287,254.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-12 $112,842,232.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-01 $149,497,381.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-02 $179,252,725.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-03 $115,768,477.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-04 $138,129,611.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-05 $125,778,096.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-06 $222,818,777.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-07 $333,708,441.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-08 $158,688,561.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-09 $213,421,847.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-10 $146,507,844.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-11 $100,324,951.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-12 $101,152,115.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-01 $83,772,390.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-02 $167,173,565.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-03 $122,708,743.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-04 $108,376,474.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-05 $123,523,123.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-06 $160,461,287.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-07 $301,186,432.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-08 $164,091,572.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-09 $149,084,316.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-10 $88,745,864.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-11 $160,414,094.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-12 $167,643,873.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-01 $92,989,657.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-02 $91,709,538.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-03 $117,265,315.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-04
Value of Goods Entering US: Since 2009 (USD)
| Top 10 suppliers | |
|---|---|
| Belgium | $3,345,634,545 |
| Canada | $1,734,424,924 |
| United Kingdom | $1,558,938,564 |
| France | $685,210,875 |
| Germany | $416,574,645 |
| Subscribers only | $229,069,991 |
| Subscribers only | $201,357,177 |
| Switzerland | $33,654,868 |
| Subscribers only | $9,897,867 |
| Subscribers only | $7,211,485 |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
Belgium exported $3,345,634,545.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. Canada exported $1,734,424,924.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. United Kingdom exported $1,558,938,564.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. France exported $685,210,875.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. Germany exported $416,574,645.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $229,069,991.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $201,357,177.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. Switzerland exported $33,654,868.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $9,897,867.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $7,211,485.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $4,050,118.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $1,523,835.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. Brazil exported $1,100,040.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $716,061.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $187,487.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $166,511.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $125,332.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $78,826.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $43,500.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $41,180.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. South Africa exported $31,658.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $8,270.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $6,500.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $4,968.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $2,610.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US.
Change in Market Share
Largest Change
| Subscribers only | 4.3% |
| Subscribers only | 1.2% |
| Subscribers only | 0.7% |
| Subscribers only | 0.6% |
| Australia | 0.5% |
| Ireland | 0.4% |
| Denmark | 0.2% |
| Canada | -6.8% |
| Italy | -0.7% |
| United Kingdom | -0.4% |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 4.271%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 1.203%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 0.747%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 0.634%.
Australia increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 0.462%.
Ireland increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 0.383%.
Denmark increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 0.222%.
United Kingdom decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -0.426%.
Italy decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -0.670%.
Canada decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -6.793%.
Top Global Suppliers: $1,000 exported — Showing countries that have shipped 3002.20.00.00
| 2009 | 2010 | 2011 | 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| * | Country | Share | Trend | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All |
100%
|
64,589 | 50,621 | 83,964 | 72,254 | 83,800 | 93,204 | 151,386 | 175,210 | 254,972 | 219,861 | 359,122 | 418,136 | 226,429 | 173,402 | 178,032 | 61,210 | 82,470 | 157,839 | 262,446 | 382,206 | 232,363 | 130,494 | 43,726 | 75,287 | 112,842 | 149,497 | 179,253 | 115,768 | 138,130 | 125,778 | 222,819 | 333,708 | 158,689 | 213,422 | 146,508 | 100,325 | 101,152 | 83,772 | 167,174 | 122,709 | 108,376 | 123,523 | 160,461 | 301,186 | 164,092 | 149,084 | 88,746 | 160,414 | 167,644 | 92,990 | 91,710 | 117,265 | ||||
| 1. | Belgium |
41%
|
43,238 | 27,643 | 51,664 | 31,338 | 47,026 | 47,896 | 75,459 | 42,542 | 58,982 | 20,065 | 61,848 | 76,814 | 50,732 | 97,899 | 90,560 | 19,991 | 40,060 | 71,768 | 67,597 | 77,691 | 78,194 | 64,934 | 32,679 | 35,872 | 63,852 | 103,380 | 149,494 | 48,897 | 79,723 | 51,521 | 73,698 | 111,691 | 60,274 | 129,689 | 63,824 | 24,915 | 54,914 | 40,490 | 88,616 | 58,873 | 52,389 | 59,976 | 59,243 | 117,119 | 74,110 | 67,625 | 43,565 | 100,427 | 131,659 | 50,121 | 25,626 | 47,431 | |||
| 2. | Canada |
21%
|
10,426 | 10,931 | 18,538 | 14,631 | 21,040 | 16,255 | 36,458 | 24,273 | 54,324 | 35,975 | 120,736 | 162,224 | 98,686 | 54,051 | 40,977 | 17,221 | 11,411 | 37,553 | 71,320 | 82,740 | 11,248 | 22,717 | 581 | 31,657 | 24,739 | 21,088 | 15,997 | 26,030 | 19,514 | 32,432 | 53,051 | 53,766 | 43,849 | 34,004 | 37,703 | 29,366 | 34,067 | 22,122 | 22,523 | 16,153 | 21,027 | 25,405 | 38,278 | 33,344 | 12,001 | 27,338 | 10,655 | 17,542 | 18,918 | 8,545 | 11,773 | 17,223 | |||
| 3. | United Kingdom |
19%
|
5.80 | 0 | 55 | 0 | 1,503 | 16 | 2,147 | 46,402 | 113,055 | 116,690 | 156,132 | 153,461 | 62,766 | 4,145 | 4,691 | 13,298 | 9,999 | 25,151 | 84,522 | 189,177 | 80,775 | 0 | 3,679 | 0 | 482 | 41 | 3,024 | 4,531 | 10,366 | 25,798 | 45,992 | 134,324 | 23,465 | 5,681 | 19 | 1,798 | 977 | 0 | 5,482 | 4,084 | 11,067 | 9,467 | 12,969 | 94,853 | 52,941 | 17,058 | 2,360 | 6,858 | 5.18 | 356 | 4,167 | 13,106 | |||
| 4. | France |
8%
|
8,798 | 8,444 | 8,459 | 21,611 | 10,228 | 15,951 | 15,585 | 14,044 | 20,887 | 18,375 | 25 | 9,219 | 7,226 | 16,689 | 25,259 | 5,513 | 9,310 | 11,950 | 16,330 | 8,400 | 11,769 | 21,313 | 2,989 | 7,439 | 21,309 | 22,823 | 3,512 | 14,880 | 23,144 | 12 | 12,068 | 8,378 | 15,502 | 23,824 | 5,800 | 26,093 | 5,124 | 6.91 | 13,493 | 27,551 | 18,292 | 4,088 | 19,164 | 17,251 | 3,458 | 11,187 | 13,511 | 19,525 | 3,504 | 15,906 | 29,501 | 10,490 | |||
| 5. | Germany |
5%
|
0 | 3,599 | 3,878 | 3,423 | 3,413 | 765 | 3,285 | 30,201 | 5,034 | 15,169 | 19,783 | 7,316 | 5,815 | 568 | 0 | 0 | 8,956 | 8,519 | 933 | 17,048 | 31,832 | 16,185 | 0 | 9.56 | 0 | 2,130 | 644 | 3,039 | 3,501 | 25 | 8,881 | 1,289 | 1,777 | 10,600 | 24,508 | 17,318 | 4,813 | 3,853 | 19,644 | 15,363 | 3,466 | 15,382 | 7,681 | 11,510 | 19,581 | 4,456 | 16,847 | 10,421 | 5,118 | 9,929 | 6,847 | 2,218 | |||
| 6. | Subscribers only |
3%
|
916 | 0 | 47 | 0 | 0 | 0 | 0 | 0 | 0 | 46 | 543 | 1,259 | 0 | 0 | 14,369 | 5,187 | 0 | 25 | 20,822 | 180 | 3,474 | 4.02 | 2,874 | 299 | 1,889 | 0 | 6,406 | 18,321 | 0 | 2,121 | 8,918 | 5,194 | 12,520 | 9,624 | 12,880 | 784 | 0 | 17,174 | 16,380 | 640 | 0 | 0 | 0 | 0 | 65 | 19,689 | 1,775 | 45 | 7,572 | 7,793 | 12,964 | 16,271 | |||
| 7. | Subscribers only |
2%
|
0 | 0 | 0 | 0 | 0 | 11,718 | 16,282 | 17,684 | 2,159 | 11,525 | 53 | 7,024 | 94 | 2.97 | 0 | 0 | 772 | 2,119 | 0 | 6,236 | 13,934 | 3,196 | 0 | 0 | 0 | 0 | 0 | 0 | 1,185 | 13,202 | 19,441 | 18,315 | 638 | 0 | 0 | 38 | 0 | 62 | 0 | 21 | 0 | 7,589 | 23,046 | 23,137 | 1,867 | 0 | 0 | 0 | 0 | 19 | 0 | 0 | |||
| 8. | Switzerland |
<1%
|
1,205 | 0 | 602 | 1,205 | 0 | 602 | 602 | 0 | 0 | 1,205 | 0 | 0 | 566 | 0 | 1,448 | 0 | 817 | 752 | 897 | 0 | 1,132 | 29 | 922 | 0 | 564 | 0 | 163 | 0 | 680 | 631 | 654 | 655 | 635 | 0 | 0 | 0 | 1,132 | 0 | 876 | 0 | 2,069 | 1,460 | 0 | 3,069 | 0 | 1,726 | 0 | 1,691 | 818 | 0 | 818 | 4,030 | |||
| 9. | Subscribers only |
<1%
|
0 | 0 | 697 | 0 | 0 | 0 | 1,558 | 10 | 0 | 796 | 0 | 809 | 0 | 0 | 727 | 0 | 0 | 0 | 0 | 736 | 0 | 718 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.16 | 0 | 0 | 0 | 0 | 5.00 | 0 | 4.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,835 | 0 | 0 | 0 | 0 | |||
| 10. | Subscribers only |
<1%
|
0 | 0 | 0 | 4.37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.79 | 0 | 11 | 6.75 | 7.12 | 13 | 20 | 7.83 | 0 | 4.67 | 14 | 21 | 0 | 50 | 0 | 14 | 0 | 154 | 15 | 62 | 153 | 68 | 22 | 8.25 | 4.50 | 18 | 7.29 | 0 | 3.47 | 15 | 6,497 | |||
| 11. | Subscribers only |
<1%
|
0 | 0 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.01 | 0 | 26 | 0 | 0 | 1,390 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,723 | 6.82 | 0 | 0 | 0 | 0 | 0 | 2.78 | 0 | 871 | 0 | 0 | 0 | 0 | 0 | 2.48 | 0 | 0 | |||
| 12. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 455 | 0 | 0 | 0 | 510 | 0 | 0 | 0 | 545 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.16 | 2.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.70 | 0 | 0 | |||
| 13. | Brazil |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 14. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 126 | 0 | 0 | 51 | 0 | 13 | 0 | 0 | 0 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30 | 0 | 50 | 0 | 31 | 0 | 0 | 7.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 47 | 0 | 305 | 0 | 0 | |||
| 15. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60 | 0 | 0 | 0 | 0 | 3.04 | 0 | 58 | 0 | 0 | 17 | 51 | 0 | 0 | 0 | |||
| 16. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 8.75 | 0 | 21 | 0 | 0 | 5.67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 111 | 0 | 0 | 0 | 0 | 0 | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 17. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.81 | 0 | 109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 18. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 79 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 19. | Subscribers only |
<1%
|
0 | 0 | 0 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 20. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.28 | 0 | 0 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 21. | South Africa |
<1%
|
0 | 2.88 | 0 | 2.16 | 9.54 | 0 | 0 | 2.38 | 0 | 0 | 3.18 | 0 | 0 | 0 | 0 | 0 | 3.63 | 2.96 | 0 | 0 | 0 | 0 | 2.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 22. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 23. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 24. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 25. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Import | Export | Description |
|---|---|---|
| 30 | 30 | Pharmaceutical products |
| 3002 | 3002 | Pharmaceutical products: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: |
| 3002.20 | 3002.20 | Vaccines for human medicine |
| 3002.20.00 | 3002.20.00 | Vaccines for human medicine |
| 3002.20.00.00 | 3002.20.00.00 | Pharmaceutical products: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine |